Adams Kendra Insider Trades

Insider Trading History

Track insider trading activity for Adams Kendra. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $1.67M 400,479 shares
Last Trade
Feb 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.5k 30,950 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $1.61M 385,098 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.1k 15,381 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $1.68M 402,342 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$454k 240,000 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $1.68M 402,342 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.09k 3,750 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $1.67M 400,479 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.52k 1,863 shares
$1.89
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $677k 162,342 shares
Last Trade
Sep 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.21k 2,775 shares
$3.32
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $689k 165,117 shares
Last Trade
Sep 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.8k 6,250 shares
$3.32
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $708k 169,676 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$415k 130,600 shares
$3.18
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $689k 165,117 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.5k 4,559 shares
$3.18
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $344k 82,576 shares
Last Trade
Feb 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.96k 1,863 shares
$3.20
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $352k 84,439 shares
Last Trade
Nov 07, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.66k 1,102 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $43.8k 10,500 shares
Last Trade
Nov 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.7k 3,750 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $357k 85,541 shares
Last Trade
Nov 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.7k 3,750 shares
$6.04
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $341k 81,791 shares
Last Trade
Sep 18, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.7k 1,837 shares
$6.38
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $59.4k 14,250 shares
Last Trade
Sep 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.3k 2,250 shares
$6.36
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $351k 84,289 shares
Last Trade
Sep 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.3k 2,250 shares
$6.36
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $349k 83,628 shares
Last Trade
Sep 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.2k 661 shares
$6.36
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $188k 45,000 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$476k 45,000 shares
$10.58
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 07, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$476k 45,000 shares
$10.58
$4.17
C4 Therapeutics
C4 Therapeutics CCCC
Chief Financial Officer
Holding Value $689k 165,300 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.21M 165,300 shares
$7.31
$4.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up